What AI says about VivoSim Labs

VivoSim develops human-relevant 3D liver and intestinal toxicology models called NAMkind™ to accelerate drug lead selection and de-risk compound development. The company offers customizable study designs, species-specific variants, and modular assay panels to provide actionable safety insights before costly animal studies or clinical trials.

AI named VivoSim Labs in January 2026.

Markets